Select publications

Publications discussed by Dr Smith

Messing EM et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 1999;341(24):1781-8. Abstract

Roach M 3rd et al; Radiation Therapy Oncology Group 9413. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 2003;21(10):1904-11. Abstract

See WA et al; Casodex Early Prostate Cancer Trialist Group. Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: First analysis of the early prostate cancer program. J Urol 2002;168(2):429-35. Abstract

Smith MR et al. Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer. Urology 2003;61(1):127-31. Abstract

Smith MR et al. Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. J Urol 2003;169(6):2008-12. Abstract

Smith MR et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab 2002;87(2):599-603. Abstract

Smith MR et al. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med 2001;345(13):948-55. Abstract

Home

Editor’s Note:
Doctors with cancer

Peter R Carroll, MD
    - Select publications

Matthew R Smith, MD, PhD
    - Select publications

Arif Hussain, MD
    - Select publications

CME Information

Faculty Disclosures

Editor’s Office